A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.
Some professionals said the popularity for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.
Service Response and Content Elimination
Based on the social media company, the platform has taken down problematic content and banned associated keywords and query recommendations. The organization said it was committed to keeping the service secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Investigations also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at residence.
Within moments of entering one group, a vendor posted contact information, where the majority of purchases take place. The vendor provided an guidebook and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, health issues or past usage.
Item Information and Costs
Inside these communities, posts display black plastic packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has already encountered individuals injured by personal administration from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to possibly significant health risks”.
